Health care stocks were higher Monday afternoon, with the NYSE Health Care Index rising 0.8% and the Health Care Select Sector SPDR Fund (XLV) up 0.6%.
The iShares Biotechnology ETF (IBB) added 0.3%.
In corporate news, Ikena Oncology (IKNA) and clinical-stage biotech company Inmagene Biopharmaceuticals said Monday they have agreed to merge, in a deal that will result in the latter owning about 43.5% of the combined company. Ikena shares surged 13%.
XBiotech (XBIT) shares sank past 27% after it said it's pausing its rheumatology clinical program due to irregularities in a phase 2 study of its candidate drug Natrunix for rheumatoid arthritis.
Spectral AI (MDAI) shares popped 10%. The company said Monday it received a letter from Nasdaq on Friday confirming that it has regained compliance with the exchange's listing rules.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。